Healthcare Sector

PFE

Market Tracker

  • PFE (Selected)

    Pfizer Inc.
  • PFEB

    Innovator S&P 500 Power Buffer ETF - February

PFE Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

PFE Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

PFE Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

PFE Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
07/02/2026 CALL $24.50 10,063 +4,535 +82.04%
07/02/2026 CALL $25.00 9,648 +3,931 +68.76%
07/02/2026 PUT $24.00 4,851 +2,719 +127.53%
09/18/2026 CALL $26.00 24,123 +1,665 +7.41%
07/31/2026 CALL $25.00 3,366 +1,557 +86.07%
07/10/2026 CALL $25.00 4,174 +1,413 +51.18%
08/21/2026 CALL $29.00 2,510 -106 -4.05%
07/10/2026 CALL $26.00 3,461 -110 -3.08%
09/18/2026 CALL $30.00 28,743 -293 -1.01%
07/17/2026 CALL $27.00 17,320 -375 -2.12%
07/02/2026 PUT $26.00 342 -739 -68.36%
09/18/2026 CALL $29.00 23,004 -1,479 -6.04%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

PFE Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 2.94% 165.24M 7.61B
Vanguard 500 Index Fund 2.21% 124.19M 5.72B
Washington Mutual Investors Fund 1.35% 76.03M 3.5B
Income Fund of America Inc 1.13% 63.51M 2.92B
SPDR S&P 500 ETF Trust 1.07% 60.16M 2.77B
Fidelity 500 Index Fund 1.06% 59.56M 2.74B
American Balanced Fund 1.06% 59.6M 2.74B
Vanguard Specialized-Health Care Fund 0.99% 55.6M 2.56B
iShares Core S&P 500 ETF 0.89% 49.69M 2.29B
Vanguard Index-Value Index Fund 0.86% 48.52M 2.23B
Vanguard Institutional Index Fund-Institutional Index Fund 0.74% 41.57M 1.91B
Vanguard/Wellington Fund Inc. 0.64% 36.07M 1.66B
Vanguard Fenway Funds-Equity Income Fund 0.58% 32.43M 1.49B
MFS Series Trust I-MFS Value Fund 0.53% 29.66M 1.37B
Fundamental Investors Inc 0.48% 27.19M 1.25B

PFE News

  • Big Pharma Has a Case of Merger Mania

    06/30 12:26 am

    The Motley Fool

    Read more
  • AbbVie Stock Hits a New 52-Week High. Has It Gotten Too Expensive to Buy?

    06/29 11:21 am

    The Motley Fool

    Read more
  • A CFO Departure. A Clinical Miss. A $43 Billion Question Mark. Should You Throw in the Towel on Pfizer Stock?

    06/28 04:30 am

    The Motley Fool

    Read more
  • Opinion: Pfizer Is a Fantastic Dividend Stock for Income Investors to Buy Right Now

    06/27 03:15 pm

    The Motley Fool

    Read more
  • An Analyst Just Declared Eli Lilly the "Clear Winner" of an American Diabetes Association Conference Focused on Weight-Loss Drugs. Novo's Chief Scientist Disagrees. Who's Right?

    06/25 11:18 am

    The Motley Fool

    Read more
  • Oblenio Bio Closes $62 Million Series B to Advance Tri-specific T-Cell Engager LBL-051 for Autoimmune Diseases into Clinical Development

    06/25 06:00 am

    GlobeNewswire Inc.

    Read more
  • 2 High-Yield Dividend Stocks to Buy and Hold for a Decade

    06/23 04:30 pm

    The Motley Fool

    Read more
  • Could Pfizer Stock Be Your Ticket to Generational Wealth?

    06/21 09:15 pm

    The Motley Fool

    Read more
  • Want to Retire on $500,000? 3 Stocks to Buy and Never Sell

    06/21 04:24 am

    The Motley Fool

    Read more
  • Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors?

    06/20 05:15 pm

    The Motley Fool

    Read more
  • Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

    06/18 07:09 pm

    The Motley Fool

    Read more
  • FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens

    06/18 11:29 am

    Benzinga

    Read more
  • Bio Usawa Appoints Dr. Aida Habtezion, Former Chief Medical Officer at Pfizer, to its Board of Directors

    06/15 04:00 am

    GlobeNewswire Inc.

    Read more
  • How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.

    06/13 06:15 pm

    The Motley Fool

    Read more
  • Pfizer's New Weight-Loss Data Just Gave Eli Lilly and Novo Nordisk Investors Something to Worry About

    06/12 12:32 pm

    The Motley Fool

    Read more
  • Value Investors Question SpaceX's Record IPO: 'It's The Future That Kills You'

    06/12 10:57 am

    Benzinga

    Read more
  • Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.

    06/11 02:02 pm

    The Motley Fool

    Read more
  • Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

    06/11 01:18 pm

    Investing.com

    Read more
  • Metastatic Prostate Cancer Market Set for Robust Growth Through 2036, Driven by The Emergence of PARP Inhibitors and PSMA-targeted Radioligand Therapies | DelveInsight

    06/10 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Pfizer's Obesity Drug Shows 16% Weight Loss In Phase 2b Study

    06/08 02:06 pm

    Benzinga

    Read more
  • 3 Dividend Stocks to Buy Hand Over Fist in June

    06/07 01:30 am

    The Motley Fool

    Read more
  • Can Pfizer's Dividend Survive the Patent Cliff? This $10.5 Billion Cancer Bet Could Hold the Answer.

    06/06 01:32 pm

    The Motley Fool

    Read more
  • Pfizer's 6.7% Yield Looks Scary -- but the Dividend Story Is Stronger Than It Seems

    06/06 12:15 pm

    The Motley Fool

    Read more
  • Arvinas Joins The Michael J. Fox Foundation’s LITE and PPMI Programs to Advance New Therapies Targeting LRRK2 for Parkinson’s Disease

    06/04 08:00 am

    GlobeNewswire Inc.

    Read more
  • Better High-Yield Dividend Stock to Buy: Bristol Myers Squibb or Pfizer?

    06/04 02:30 am

    The Motley Fool

    Read more
  • Levicept to Present Data Suggesting LEVI-04 May Modify Disease in Osteoarthritis at EULAR 2026

    06/03 04:00 am

    GlobeNewswire Inc.

    Read more
  • Why Bristol Myers Squibb Stock Isn't Nearly As Cheap As It Looks

    06/01 11:15 pm

    The Motley Fool

    Read more
  • AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

    06/01 02:19 pm

    The Motley Fool

    Read more
  • CRISPR Therapeutics' Secret Weapon That Many Investors Are Overlooking

    06/01 12:30 pm

    The Motley Fool

    Read more
  • Bay Area Lyme Foundation Raises $900,000 at LymeAid 2026, Presenting Inaugural Neil L. Spector, MD, Legacy Award and $300,000 in Emerging Leader Grants

    05/28 02:00 pm

    GlobeNewswire Inc.

    Read more
  • This Healthcare Stock With 6%-Plus Yield: Is the Dividend Safe?

    05/25 05:15 pm

    The Motley Fool

    Read more
  • Tacrolimus Market Research Report 2026: Key Growth Drivers, Challenges, Future Opportunities, and Regulatory Landscape 2025-2035

    05/25 05:31 am

    GlobeNewswire Inc.

    Read more
  • Eli Lilly Just Made a Game-Changing Move in the Billion-Dollar Weight Loss Drug Space. Here's What You Need to Know.

    05/25 05:05 am

    The Motley Fool

    Read more
  • Is Relay Therapeutics a Buy After Promising Trial Results?

    05/22 05:30 pm

    The Motley Fool

    Read more
  • The Most Important Healthcare Stock You're Not Watching

    05/22 05:15 pm

    The Motley Fool

    Read more
  • The Most Undervalued Healthcare Stock in the S&P 500 Right Now

    05/21 07:05 am

    The Motley Fool

    Read more
  • ESR1-Mutated Metastatic Breast Cancer Market Expected to Grow Rapidly at 9.6% CAGR During the Forecast Period (2026–2036) Due to the Emergence of Novel Oral SERDs and Targeted Agents | DelveInsight

    05/20 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Pfizer Expands Pneumococcal Vaccine Push With New Programs

    05/20 09:14 am

    Benzinga

    Read more
  • Pulmonary Arterial Hypertension Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

    05/19 01:00 pm

    GlobeNewswire Inc.

    Read more
  • Arbor Biotechnologies Appoints Mathew Pletcher, Ph.D., as Chief Scientific Officer

    05/18 10:00 am

    GlobeNewswire Inc.

    Read more
  • 2 Ways to Play the Big Pharma Patent Cliff

    05/15 10:18 am

    Investing.com

    Read more
  • My Top 3 Healthcare Stocks for May 2026

    05/15 08:33 am

    The Motley Fool

    Read more
  • Why Doximity Stock Plunged Today

    05/14 11:03 am

    The Motley Fool

    Read more
  • Should Eli Lilly Investors Worry About Its Newest Rival -- From Within?

    05/14 05:05 am

    The Motley Fool

    Read more
  • Global Colorectal Cancer Diagnostics and Therapeutics Market Anticipates Impressive Growth Trajectory at a CAGR of ~9% by 2034 | DelveInsight

    05/13 01:00 pm

    GlobeNewswire Inc.

    Read more
  • 3 Struggling Stocks That Could Make for Great Contrarian Buys

    05/13 09:30 am

    The Motley Fool

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: